Loyola testing new device for treating Atrial Fibrillation

Loyola University Medical Center is testing a high-tech catheter device that's intended to improve outcomes of patients treated for atrial fibrillation, the most common irregular heartbeat.

The treatment, called , involves burning selected spots of tissue inside the heart. This eliminates the sources of errant electrical signals that are triggering the .

In a-fib, electrical signals that regulate the heartbeat become erratic. Instead of beating regularly, the upper chambers of the heart quiver. Not all the blood gets pumped out, so clots can form. A-fib can lead to strokes and .

Loyola is participating in a multicenter clinical trial of a new pressure-sensing . The device tells the physician the precise direction of the catheter and how hard it is pushing against the heart wall. This information is graphically displayed on a 3-D mapping and .

The investigational device is called the SmartTouch® Contact Force Sensing Catheter. In the clinical trial, patients who undergo ablation with the pressure-sensing catheter will be compared with a group of similar patients who have undergone ablation with conventional catheters.

Principal investigator at the Loyola site is Dr. David Wilber, one of the nation's leading researchers in catheter ablation. Wilber is director of Loyola University Chicago Stritch School of Medicine's Cardiovascular Institute and medical director of Clinical Electrophysiology.

Atrial fibrillation patient Gregg Sunday of Naperville, Ill., was among the first Loyola patients to participate in the clinical trial of the pressure-sensing catheter. Atrial fibrillation caused an unsettling feeling in Sunday's chest and left him easily winded during physical activity. Medications initially controlled the condition but became less effective.

Sunday, 51, underwent ablation on a recent Thursday. He spent one night in the hospital and was back at work the following Monday. His heart rhythm has returned to normal and he will be able to taper off his medications.

"I'm so happy I was able to participate in this clinical trial," he said.

More than 2 million Americans have atrial fibrillation, also known as a-fib. There are about 160,000 new cases each year. The number is increasing due in part to the aging population and the obesity epidemic.

A-fib symptoms include heart palpitations, dizziness, chest pain, fatigue, shortness of breath, fainting and lightheadedness. "A lot of people are disabled," Wilber said. "They have no energy. They can't work. They have a very poor quality of life."

Medications can maintain a normal heart rhythm. But when drugs don't work or cause unacceptable side effects, alternative treatments include surgery or catheter ablation. While drugs have been available for more than 30 years, ablation is a relatively new treatment.

In the ablation procedure, an electrophysiologist inserts a catheter (thin flexible tube) in a groin artery and guides it through blood vessels to the heart. The tip of the catheter delivers radiofrequency energy that heats and destroys tissue that sends out erratic .

The challenge is to press the catheter firmly enough against the wall of the heart so that sufficient tissue is destroyed, without pushing so hard that the catheter punches a hole in the .

"This requires a very fine balance, which is difficult to achieve, even for an experienced operator," Wilber said. "The pressure-sensing catheter, if proven safe and effective, potentially could improve patient outcomes and the durability of ablation treatments."

add to favorites email to friend print save as pdf

Related Stories

Landmark heart treatment study

Jan 26, 2010

Treating a common heart rhythm disorder by burning heart tissue with a catheter works dramatically better than drug treatments, according to a landmark study published in the Jan. 27 issue of the Journal of the American Me ...

Recommended for you

Ebola reveals shortcomings of African solidarity

18 hours ago

As Africa's leaders meet in Ethiopia to discuss the Ebola crisis, expectations of firm action will be tempered by criticism over the continent's poor record in the early stages of the epidemic.

Second bird flu case confirmed in Canada

Jan 30, 2015

The husband of a Canadian who was diagnosed earlier this week with bird flu after returning from a trip to China has also tested positive for the virus, health officials said Friday.

What exactly is coronavirus?

Jan 30, 2015

The conflicts in Syria and Iraq are straining public health systems and public health efforts meant to prevent and detect the spread of infectious diseases. This is generating a "perfect storm" of conditions for outbreaks. Among the infections raising concern is Middle East Respiratory Syndrome, caused by a type of coronavirus, which emerged in 2012. ...

Scientists find Ebola virus is mutating

Jan 30, 2015

(Medical Xpress)—Researchers working at Institut Pasteur in France have found that the Ebola virus is mutating "a lot" causing concern in the African countries where the virus has killed over eight thous ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.